Atlas Trials

A Study to Investigate the Antidepressant Mechanism-of-action of JNJ-42847922 in Participants With Major Depressive Disorder

Clinical trial NCT03374475 · COMPLETED

Trial details

NCT number
NCT03374475
Sponsor
Janssen Research & Development, LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Depressive Disorder, Major
Start date
2018-01-05
Primary completion
2019-04-29
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.